143 related articles for article (PubMed ID: 36823223)
1. The effect of a brief, unplanned treatment delay on neovascular age-related macular degeneration patients: a retrospective cohort study.
Zehden JA; Ghosh A; Soundararajan S; Tsujimoto THM; Jiang H; Lin FC; Blahnik T; Fleischman D; Zhang AY
Sci Rep; 2023 Feb; 13(1):3156. PubMed ID: 36823223
[TBL] [Abstract][Full Text] [Related]
2. Long-term impact of delayed follow-up due to COVID-19 lockdown on patients with neovascular age-related macular degeneration.
Szegedi S; Ebner C; Miháltz K; Wachter T; Vécsei-Marlovits PV
BMC Ophthalmol; 2022 May; 22(1):228. PubMed ID: 35596203
[TBL] [Abstract][Full Text] [Related]
3. Long-term Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: The LATAR Study: Report 1: Ten-Year, Real-World Outcomes.
Spooner K; Fraser-Bell S; Hong T; Phan L; Wong JG; Chang A
Ophthalmol Retina; 2021 Jun; 5(6):511-518. PubMed ID: 33007523
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Eyes Lost to Follow-up with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Anti-Vascular Endothelial Growth Factor.
Soares RR; Mellen P; Garrigan H; Obeid A; Wibbelsman TD; Borkar D; Ho AC; Hsu J
Ophthalmol Retina; 2020 Feb; 4(2):134-140. PubMed ID: 31540854
[TBL] [Abstract][Full Text] [Related]
5. Delayed follow-up of medical retina patients due to COVID-19: impact on disease activity and visual acuity.
Stone LG; Grinton ME; Talks JS
Graefes Arch Clin Exp Ophthalmol; 2021 Jul; 259(7):1773-1780. PubMed ID: 33977317
[TBL] [Abstract][Full Text] [Related]
6. Real-life management of neovascular age-related macular degeneration (nAMD) in France: a nationwide observational study using retrospective claims data.
Korobelnik JF; Delcourt C; Creuzot-Garcher C; Melaine A; Chassetuillier J; Lejeune A; Bénard S; Dupont-Benjamin L
J Med Econ; 2021; 24(1):1087-1097. PubMed ID: 34420480
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes.
Zhu M; Chew JK; Broadhead GK; Luo K; Joachim N; Hong T; Syed A; Chang AA
Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1217-25. PubMed ID: 25205618
[TBL] [Abstract][Full Text] [Related]
8. Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies.
Carrasco J; Pietsch GA; Nicolas MP; Koerber C; Bennison C; Yoon J
Adv Ther; 2020 Jan; 37(1):300-315. PubMed ID: 31728825
[TBL] [Abstract][Full Text] [Related]
9. A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration.
Park DH; Sun HJ; Lee SJ
Int Ophthalmol; 2017 Oct; 37(5):1205-1214. PubMed ID: 27826933
[TBL] [Abstract][Full Text] [Related]
10. Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational Study.
Gillies MC; Nguyen V; Daien V; Arnold JJ; Morlet N; Barthelmes D
Ophthalmology; 2016 Dec; 123(12):2545-2553. PubMed ID: 27707549
[TBL] [Abstract][Full Text] [Related]
11. Management and Outcomes for Neovascular Age-Related Macular Degeneration: Analysis of United States Electronic Health Records.
Kiss S; Campbell J; Almony A; Shih V; Serbin M; LaPrise A; Wykoff CC
Ophthalmology; 2020 Sep; 127(9):1179-1188. PubMed ID: 32345477
[TBL] [Abstract][Full Text] [Related]
12. Visual acuity outcomes of anti-VEGF treatment for neovascular age-related macular degeneration in clinical trials.
Yamashiro K; Oishi A; Hata M; Takahashi A; Tsujikawa A
Jpn J Ophthalmol; 2021 Nov; 65(6):741-760. PubMed ID: 34491474
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Poor Visual Outcomes of Neovascular Age-related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor Agents.
Nguyen CL; Gillies MC; Nguyen V; Daien V; Cohn A; Banerjee G; Arnold J;
Ophthalmology; 2019 May; 126(5):735-742. PubMed ID: 30529685
[TBL] [Abstract][Full Text] [Related]
14. Effects of the COVID-19 pandemic on neovascular age-related macular degeneration and response to delayed Anti-VEGF treatment.
Yeter DY; Dursun D; Bozali E; Ozec AV; Erdogan H
J Fr Ophtalmol; 2021 Mar; 44(3):299-306. PubMed ID: 33608176
[TBL] [Abstract][Full Text] [Related]
15. Effects of delay in anti-vascular endothelial growth factor intravitreal injections for neovascular age-related macular degeneration.
Hanhart J; Wiener R; Totah H; Gelman E; Weill Y; Abulafia A; Zadok D
Graefes Arch Clin Exp Ophthalmol; 2022 Jun; 260(6):1907-1914. PubMed ID: 35013800
[TBL] [Abstract][Full Text] [Related]
16. Enhanced depth imaging of the choroid in patients with neovascular age-related macular degeneration treated with anti-VEGF therapy versus untreated patients.
Rahman W; Chen FK; Yeoh J; da Cruz L
Graefes Arch Clin Exp Ophthalmol; 2013 Jun; 251(6):1483-8. PubMed ID: 23160538
[TBL] [Abstract][Full Text] [Related]
17. The association of exudation pattern with anatomical and functional outcomes in patients with Neovascular Age-Related Macular Degeneration.
Inan S; Polat O; Karadas M; Inan UU
Rom J Ophthalmol; 2019; 63(3):238-244. PubMed ID: 31687625
[No Abstract] [Full Text] [Related]
18. Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Neovascular Age-Related Macular Degeneration Patients: A Real-World Analysis of 49 485 Eyes.
Ciulla TA; Hussain RM; Pollack JS; Williams DF
Ophthalmol Retina; 2020 Jan; 4(1):19-30. PubMed ID: 31324588
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Intentionally Suspending Treatment in Eyes With Advanced Neovascular Age-Related Macular Degeneration.
Awh KC; Mahmoudzadeh R; Salabati M; Mansour HA; Bechay J; Magagna J; Regillo CD; Ho AC; Garg SJ; Hsu J
Am J Ophthalmol; 2023 Dec; 256():20-26. PubMed ID: 37517527
[TBL] [Abstract][Full Text] [Related]
20. SEVERE VISUAL LOSS DURING ANTI-VEGF INTRAVITREAL INJECTIONS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: TIMING, PROGNOSIS, AND OPTICAL COHERENCE TOMOGRAPHY FINDINGS.
Grassi MO; Monteleone G; Pozharitskiy N; Molfetta T; Boscia G; Alessio G; Boscia F
Retina; 2023 Jul; 43(7):1081-1087. PubMed ID: 36913628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
